These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 3427459)

  • 1. Do piracetam-like compounds act centrally via peripheral mechanisms?
    Mondadori C; Petschke F
    Brain Res; 1987 Dec; 435(1-2):310-4. PubMed ID: 3427459
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The memory-enhancing effects of the piracetam-like nootropics are dependent on experimental parameters.
    Mondadori C; Ducret T; Borkowski J
    Behav Brain Res; 1989 May; 33(1):79-82. PubMed ID: 2736062
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reversal of scopolamine-induced amnesia and alterations in energy metabolism by the nootropic piracetam: implications regarding identification of brain structures involved in consolidation of memory traces.
    Piercey MF; Vogelsang GD; Franklin SR; Tang AH
    Brain Res; 1987 Oct; 424(1):1-9. PubMed ID: 3690290
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of oxiracetam on learning and memory in animals: comparison with piracetam.
    Mondadori C; Classen W; Borkowski J; Ducret T; Buerki H; Schadé A
    Clin Neuropharmacol; 1986; 9 Suppl 3():S27-38. PubMed ID: 3594453
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Facilitating effect of oxiracetam and piracetam on acquisition of discrete two-way shuttle avoidance in normal mice.
    Kuribara H; Tadokoro S
    Jpn J Pharmacol; 1988 Dec; 48(4):494-8. PubMed ID: 3244203
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Avoidance facilitation by nootropics.
    Sansone M; Oliverio A
    Prog Neuropsychopharmacol Biol Psychiatry; 1989; 13 Suppl():S89-97. PubMed ID: 2616794
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 2-pyrrolidinone moiety is not critical for the cognition-enhancing activity of piracetam-like drugs.
    Scapecchi S; Martelli C; Ghelardini C; Guandalini L; Martini E; Gualtieri F
    Farmaco; 2003 Sep; 58(9):715-22. PubMed ID: 13679165
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Blockade of the nootropic action of piracetam-like nootropics by adrenalectomy: an effect of dosage?
    Mondadori C; Ducret T; Petschke F
    Behav Brain Res; 1989 Aug; 34(1-2):155-8. PubMed ID: 2765169
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effect of piracetam on passive avoidance learning in ethanol-treated mice].
    Voigt JP; Fahl G; von Rottkay F; Morgenstern E
    Biomed Biochim Acta; 1986; 45(9):1191-4. PubMed ID: 3814108
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Involvement of a steroidal component in the mechanism of action of piracetam-like nootropics.
    Mondadori C; Bhatnagar A; Borkowski J; Häusler A
    Brain Res; 1990 Jan; 506(1):101-8. PubMed ID: 2137359
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Behavioral effects of piracetam in rats with isolation syndrome.
    Petkov VV; Rousseva S; Dimov S
    Acta Physiol Pharmacol Bulg; 1984; 10(3):3-9. PubMed ID: 6543288
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of oxiracetam and piracetam on central cholinergic mechanisms and active-avoidance acquisition.
    Spignoli G; Pedata F; Giovannelli L; Banfi S; Moroni F; Pepeu G
    Clin Neuropharmacol; 1986; 9 Suppl 3():S39-47. PubMed ID: 3594455
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis of 1-azabicyclo[3.3.0]octane derivatives and their effects as piracetam-like nootropics.
    Oka M; Matsumoto Y; Hirooka K; Suzuki T
    Chem Pharm Bull (Tokyo); 2000 Aug; 48(8):1121-4. PubMed ID: 10959574
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Piracetam activity may differ according to the age of the recipient mouse.
    Valzelli L; Bernasconi S; Sala A
    Int Pharmacopsychiatry; 1980; 15(3):150-6. PubMed ID: 6165698
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reversal of scopolamine-induced alterations of choline transport across the blood-brain barrier by the nootropics piracetam and pramiracetam.
    Brust P
    Arzneimittelforschung; 1989 Oct; 39(10):1220-2. PubMed ID: 2610714
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of nootropic drugs on brain cholinergic and dopaminergic transmission.
    Pavlík A; Benesová O; Dlohozková N
    Act Nerv Super (Praha); 1987 Mar; 29(1):62-5. PubMed ID: 3035858
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prolongation of latencies for passive avoidance responses in rats treated with aniracetam or piracetam.
    Yamada K; Inoue T; Tanaka M; Furukawa T
    Pharmacol Biochem Behav; 1985 Apr; 22(4):645-8. PubMed ID: 3991773
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacological restoration of scopolamine-impaired memory.
    Petkov VV; Vuglenova Y
    Acta Physiol Pharmacol Bulg; 1985; 11(3):37-43. PubMed ID: 3938594
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effect of piracetam on the action of antidepressants (experimental data)].
    Mashkovskiĭ MD; Andreeva NI; Parshin VA
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1989; 89(2):129-31. PubMed ID: 2728714
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Failure of piracetam to facilitate acquisition or retention in younger or older rats.
    Means LW; Franklin RD; Cliett CE
    Exp Aging Res; 1980 Apr; 6(2):175-80. PubMed ID: 7389786
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.